Loading...
Shop Apotheke Europe N.V.
SAE.DE•XETRA
Healthcare
Medical - Pharmaceuticals
€88.30
€0.00(0.00%)

Over the last four quarters, Shop Apotheke Europe N.V. achieved steady financial progress, growing revenue from $372.05M in Q1 2023 to $574.55M in Q3 2024. Gross profit stayed firm with margins at 20% in Q3 2024 versus 28% in Q1 2023. Operating income totaled -$6.66M in Q3 2024, maintaining a -1% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $13.47M. Net income dropped to -$6.91M, with EPS at -$0.35. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan